Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 9028458)

1.

Neuroepigenomics: Resources, Obstacles, and Opportunities.

Satterlee JS, Beckel-Mitchener A, Little R, Procaccini D, Rutter JL, Lossie AC.

Neuroepigenetics. 2015 Jan 1;1:2-13.

PMID:
25722961
2.

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Francis SM, Sagar A, Levin-Decanini T, Liu W, Carter CS, Jacob S.

Brain Res. 2014 Sep 11;1580:199-218. doi: 10.1016/j.brainres.2014.01.021. Epub 2014 Jan 22.

3.

A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome.

Bird LM, Tan WH, Bacino CA, Peters SU, Skinner SA, Anselm I, Barbieri-Welge R, Bauer-Carlin A, Gentile JK, Glaze DG, Horowitz LT, Mohan KN, Nespeca MP, Sahoo T, Sarco D, Waisbren SE, Beaudet AL.

Am J Med Genet A. 2011 Dec;155A(12):2956-63. doi: 10.1002/ajmg.a.34297. Epub 2011 Oct 14.

4.

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

Peters SU, Bird LM, Kimonis V, Glaze DG, Shinawi LM, Bichell TJ, Barbieri-Welge R, Nespeca M, Anselm I, Waisbren S, Sanborn E, Sun Q, O'Brien WE, Beaudet AL, Bacino CA.

Am J Med Genet A. 2010 Aug;152A(8):1994-2001. doi: 10.1002/ajmg.a.33509.

5.

Angelman syndrome (AS, MIM 105830).

Van Buggenhout G, Fryns JP.

Eur J Hum Genet. 2009 Nov;17(11):1367-73. doi: 10.1038/ejhg.2009.67. Epub 2009 May 20. Review.

6.

Distinct phenotypes distinguish the molecular classes of Angelman syndrome.

Lossie AC, Whitney MM, Amidon D, Dong HJ, Chen P, Theriaque D, Hutson A, Nicholls RD, Zori RT, Williams CA, Driscoll DJ.

J Med Genet. 2001 Dec;38(12):834-45.

7.

Methylation imprinting of H19 and SNRPN genes in human benign ovarian teratomas.

Miura K, Obama M, Yun K, Masuzaki H, Ikeda Y, Yoshimura S, Akashi T, Niikawa N, Ishimaru T, Jinno Y.

Am J Hum Genet. 1999 Nov;65(5):1359-67.

8.

Imprinting-mutation mechanisms in Prader-Willi syndrome.

Ohta T, Gray TA, Rogan PK, Buiting K, Gabriel JM, Saitoh S, Muralidhar B, Bilienska B, Krajewska-Walasek M, Driscoll DJ, Horsthemke B, Butler MG, Nicholls RD.

Am J Hum Genet. 1999 Feb;64(2):397-413.

9.

Molecular mechanism of angelman syndrome in two large families involves an imprinting mutation.

Ohta T, Buiting K, Kokkonen H, McCandless S, Heeger S, Leisti H, Driscoll DJ, Cassidy SB, Horsthemke B, Nicholls RD.

Am J Hum Genet. 1999 Feb;64(2):385-96.

10.

Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis.

Buiting K, Dittrich B, Gross S, Lich C, Färber C, Buchholz T, Smith E, Reis A, Bürger J, Nöthen MM, Barth-Witte U, Janssen B, Abeliovich D, Lerer I, van den Ouweland AM, Halley DJ, Schrander-Stumpel C, Smeets H, Meinecke P, Malcolm S, Gardner A, Lalande M, Nicholls RD, Friend K, Schulze A, Matthijs G, Kokkonen H, Hilbert P, Van Maldergem L, Glover G, Carbonell P, Willems P, Gillessen-Kaesbach G, Horsthemke B.

Am J Hum Genet. 1998 Jul;63(1):170-80.

11.

Prader-Willi syndrome.

Cassidy SB.

J Med Genet. 1997 Nov;34(11):917-23. Review.

12.

Balanced translocation 46,XY,t(2;15)(q37.2;q11.2) associated with atypical Prader-Willi syndrome.

Conroy JM, Grebe TA, Becker LA, Tsuchiya K, Nicholls RD, Buiting K, Horsthemke B, Cassidy SB, Schwartz S.

Am J Hum Genet. 1997 Aug;61(2):388-94.

13.

Different mechanisms and recurrence risks of imprinting defects in Angelman syndrome.

Bürger J, Buiting K, Dittrich B, Gross S, Lich C, Sperling K, Horsthemke B, Reis A.

Am J Hum Genet. 1997 Jul;61(1):88-93.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk